Chian-Jiun Liou 

Chian-Jiun Liou

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2019 in Cells
Verified
Journal Article
Open access
PDF file
CLChian-Jiun Liou 
Chian-Jiun Liou 
YLYau-Ker Lee
Yau-Ker Lee
NTNai-Chun Ting
Nai-Chun Ting
YCYa-Ling Chen
Ya-Ling Chen
SSSzu-Chuan Shen
Szu-Chuan Shen
WHWen-Chung Huang
Wen-Chung Huang
Licochalcone A is a chalcone isolated from Glycyrrhiza uralensis. It showed anti-tumor and anti-inflammatory properties in mice with acute lung injuries and regulated lipid metabolism through the activation of AMP-activated protein kinase (AMPK) in hepatocytes. However, the effects of licochalcone A on reducing weight gain and improving nonalcoholic fatty liver disease (NAFLD) are unclear. Thus, the present study investigated whether licochalcone A ameliorated weight loss and lipid metabolism in the liver of high-fat diet (HFD)-induced obese mice. Male C57BL/6 mice were fed an HFD to induce obesity and NAFLD, and then were injected intraperitoneally with licochalcone A. In another experiment, a fatty liver cell model was established by incubating HepG2 hepatocytes with oleic acid and treating the cells with licochalcone A to evaluate lipid metabolism. Our results demonstrated that HFD-induced obese mice treated with licochalcone A had decreased body weight as well as inguinal and epididymal adipose tissue weights compared with HFD-treated mice. Licochalcone A also ameliorated hepatocyte steatosis and decreased liver tissue weight and lipid droplet accumulation in liver tissue. We also found that licochalcone A significantly regulated serum triglycerides, low-density lipoprotein, and free fatty acids, and decreased the fasting blood glucose value. Furthermore, in vivo and in vitro, licochalcone A significantly decreased expression of the transcription factor of lipogenesis and fatty acid synthase. Licochalcone A activated the sirt-1/AMPK pathway to reduce fatty acid chain synthesis and increased lipolysis and β-oxidation in hepatocytes. Licochalcone A can potentially ameliorate obesity and NAFLD in mice via activation of the sirt1/AMPK pathway.

13 February 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
WHWen-Chung Huang
Wen-Chung Huang
LFLi-Wen Fang
Li-Wen Fang
CLChian-Jiun Liou 
Chian-Jiun Liou 
Phloretin, isolated from the apple tree, was previously demonstrated to have anti-oxidative and anti-inflammatory effects in macrophages and anti-adiposity effects in adipocytes. Inflammatory immune cells generate high levels of reactive oxygen species for stimulated severe airway hyperresponsiveness (AHR) and airway inflammation. In this study, we investigated whether phloretin could reduce oxidative stress, airway inflammation, and eosinophil infiltration in asthmatic mice, and ameliorate oxidative and inflammatory responses in tracheal epithelial cells. BALB/c mice were sensitized with ovalbumin (OVA) to induce asthma symptoms. Mice were randomly assigned to the five experimental groups: normal controls; OVA-induced asthmatic mice; and OVA-induced mice injected intraperitoneally with one of the three phloretin doses (5 mg/kg, 10 mg/kg, or 20 mg/kg). In addition, we treated inflammatory human tracheal epithelial cells (BEAS-2B cells) with phloretin to assess oxidative responses and the levels of proinflammatory cytokines and chemokines. We found that phloretin significantly reduced goblet cell hyperplasia and eosinophil infiltration, which decreased AHR, inflammation, and oxidative responses in the lungs of OVA-sensitized mice. Phloretin also decreased malondialdehyde levels in the lung, and reduced Th2 cytokine production in bronchoalveolar lavage fluids. Furthermore, phloretin reduced reactive oxygen species, proinflammatory cytokines, and eotaxin production in BEAS-2B cells. Phloretin also suppressed monocyte cell adherence to inflammatory BEAS-2B cells. These findings suggested that phloretin alleviated pathological changes, inflammation, and oxidative stress by inhibiting Th2 cytokine production in asthmatic mice. Phloretin showed therapeutic potential for ameliorating asthma symptoms in the future.

1 January 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YCYi-Hsien Chang
Yi-Hsien Chang
YCYa-Ling Chen
Ya-Ling Chen
WHWen-Chung Huang
Wen-Chung Huang
CLChian-Jiun Liou 
Chian-Jiun Liou 

1 January 2014 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
WHWen-Chung Huang
Wen-Chung Huang
CCCheng-Chi Chan
Cheng-Chi Chan
SWShu-Ju Wu
Shu-Ju Wu
LCLi-Chen Chen
Li-Chen Chen
JSJiann-Jong Shen
Jiann-Jong Shen
CLChian-Jiun Liou 
Chian-Jiun Liou 

13 March 2021 in Journal of Ginseng Research
Verified
Journal Article
Open access
WHWen-Chung Huang
Wen-Chung Huang
THTse-Hung Huang
Tse-Hung Huang
KYKuo-Wei Yeh
Kuo-Wei Yeh
YCYa-Ling Chen
Ya-Ling Chen
SSSzu-Chuan Shen
Szu-Chuan Shen
CLChian-Jiun Liou 
Chian-Jiun Liou 
Ginsenoside Rg3, isolated from Panax ginseng, has anti-inflammatory and anti-tumor activities. It is known to reduce inflammation in acute lung injury in mice, and to reduce the expression of inflammatory cytokines and COX-2 in human asthmatic airway epithelium. In this study, we attempted to determine whether ginsenoside Rg3 inhibits airway inflammation, oxidative stress, and airway hyperresponsiveness (AHR) in the lungs of asthmatic mice. We also investigated its effects on oxidative stress and the inflammatory response in tracheal epithelial cells. Asthma symptoms were induced in female BALB/c mice sensitized with ovalbumin (OVA). Mice were divided into five groups: normal controls, OVA-induced asthmatic controls, and asthmatic mice treated with ginsenoside Rg3 or prednisolone by intraperitoneal injection. Inflammatory BEAS-2B cells (human tracheal epithelial cells) treated with ginsenoside Rg3 to investigate its effects on inflammatory cytokines and oxidative responses. Ginsenoside Rg3 treatment significantly reduced eosinophil infiltration, oxidative responses, airway inflammation, and AHR in the lungs of asthmatic mice. Ginsenoside Rg3 reduced Th2 cytokine and chemokine levels in bronchoalveolar lavage fluids and lung. Inflammatory BEAS-2B cells treated with ginsenoside Rg3 reduced the eotaxin and pro-inflammatory cytokine expressions, and monocyte adherence to BEAS-2B cells was significantly reduced as a result of decreased ICAM-1 expression. Furthermore, ginsenoside Rg3 reduced the expression of reactive oxygen species in inflammatory BEAS-2B cells. Ginsenoside Rg3 is a potential immunomodulator that can ameliorate pathological features of asthma by decreasing oxidative stress and inflammation

1 July 2018 in International Immunopharmacology
Verified
Journal Article
Closed access
HPHui-Ling Peng
Hui-Ling Peng
WHWen-Chung Huang
Wen-Chung Huang
SCShu-Chen Cheng
Shu-Chen Cheng
CLChian-Jiun Liou 
Chian-Jiun Liou